Pharmaprocess
Pharmaprocess, headquartered in Italy, is a leading player in the pharmaceutical and biotechnology sectors, specialising in innovative solutions for drug manufacturing and process optimisation. Founded in 2005, the company has established a strong presence across Europe and beyond, focusing on enhancing production efficiency and compliance within the industry. With a diverse portfolio of services, including process engineering, validation, and regulatory support, Pharmaprocess stands out for its commitment to quality and customer-centric solutions. The company has achieved significant milestones, such as successful collaborations with major pharmaceutical firms, solidifying its reputation as a trusted partner in the market. Recognised for its expertise and innovative approach, Pharmaprocess continues to drive advancements in pharmaceutical processes, ensuring clients meet the ever-evolving demands of the industry.
DitchCarbon Score
How does Pharmaprocess's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Salt and Mineral Mining industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmaprocess's score of 3 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaprocess's reported carbon emissions
Pharmaprocess, headquartered in Italy, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. Additionally, Pharmaprocess has not outlined any formal reduction targets or commitments to climate initiatives, which limits the ability to assess their environmental impact or sustainability efforts within the industry context. As the company moves forward, establishing clear climate commitments and reduction strategies will be essential for aligning with global sustainability goals and enhancing their corporate responsibility profile.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmaprocess is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
